Search

Illumina Inc

Avatud

SektorTervishoid

218.01 -5.69

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

217.85

Max

231.12

Põhinäitajad

By Trading Economics

Sissetulek

-268M

-134M

Müük

68M

1.2B

P/E

Sektori keskmine

40.958

57.366

Aktsiakasum

1.31

Kasumimarginaal

-11.562

Töötajad

8,600

EBITDA

80M

330M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

-14.39% downside

Dividendid

By Acuity

Järgmine tulemuste avaldamine

29. okt 2026

Turustatistika

By TradingEconomics

Turukapital

5B

34B

Eelmine avamishind

223.7

Eelmine sulgemishind

218.01

Uudiste sentiment

By Acuity

16%

84%

24 / 340 Pingereas Healthcare

Illumina Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

27. aug 2026, 20:07 UTC

Illumina Inc shares are higher during Thursday's session, supported by a decline in initial jobless claims, though no specific company news was identified.

26. aug 2026, 20:07 UTC

News

Illumina Inc shares are lower today amid a broader downturn in the Life Sciences Tools & Services sub-sector. Analysts estimate fair value at $172.53.

25. aug 2026, 20:07 UTC

News

Illumina Inc shares are advancing as investor sentiment improves ahead of a meeting with Piper Sandler scheduled for August 27.

24. aug 2026, 20:02 UTC

Social Media
News

Illumina Inc reported second-quarter earnings of $1.31 per share, with revenue of $1.16 billion, surpassing estimates. Shares are advancing during Monday's session.

21. aug 2026, 19:16 UTC

Illumina Inc shares are higher today, recovering from earlier losses and remaining above the 20-day moving average for the third consecutive session.

20. aug 2026, 20:02 UTC

Illumina Inc's shares are higher today, building on gains since Wednesday. The stock is trading near the upper end of its one-month range.

19. aug 2026, 20:02 UTC

Correlated Moves

Illumina Inc. shares are higher, buoyed by strong momentum in the genomics sector and a notable rise in the ARK Genomic Revolution ETF.

17. aug 2026, 19:54 UTC

News

Illumina Inc's stock is higher, supported by a Yahoo Finance article discussing its price target of $198.89 and concerns over organic sales performance.

13. aug 2026, 20:06 UTC

Illumina Inc's shares are lower amid declines in the Life Sciences Tools & Services sector, with no specific company news identified for the movement.

12. aug 2026, 22:02 UTC

Illumina Inc shares are lower in after-market hours with no specific news identified. Broader market conditions reflect mixed performance amid inflation data.

11. aug 2026, 19:16 UTC

Illumina Inc. shares are trading higher, recovering from an early dip during Tuesday's session. No specific news or developments were identified.

10. aug 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares fell in after-hours trading, tracking a broader decline in the Russell 2000 Index amid rising U.S. Treasury yields and inflation concerns.

7. aug 2026, 19:46 UTC

News

Illumina Inc shares are lower after Director Keith A. Meister sold 283,269 shares, raising investor concerns about the company's valuation.

6. aug 2026, 23:06 UTC

Illumina Inc shares are lower in after-market trading following Thursday's close, despite an initial uptick. No specific news was identified to explain the decline.

5. aug 2026, 19:52 UTC

Correlated Moves

Illumina shares are lower following disappointing first-quarter results and broader market declines. ADP's report on weak job growth has added to cautious sentiment.

4. aug 2026, 19:31 UTC

Correlated Moves

Illumina Inc's shares are higher today, reflecting a broader market trend as the Russell 2000 Index also advances. The stock is near its one-month range high.

3. aug 2026, 20:03 UTC

News

Illumina shares are lower today as Citigroup maintains a Sell rating and raises its price target to $113 amid mixed analyst sentiment.

31. juuli 2026, 23:06 UTC

News

Illumina Inc reported strong Q2 results and raised full-year guidance, yet shares declined in after-market trading from Friday's close of $202.95.

30. juuli 2026, 23:41 UTC

News
Social Media

Illumina Inc shares declined in after-market trading despite strong second-quarter results and raised full-year EPS guidance, reflecting concerns over falling net income.

29. juuli 2026, 23:26 UTC

Illumina Inc. shares declined after-market amid overall market volatility following the Federal Reserve's decision to maintain interest rates amid rising inflation concerns.

28. juuli 2026, 19:46 UTC

News

Illumina Inc. is acquiring contingent payments from its merger with Treeline Biosciences to enhance integration. Shares are trading higher since Monday's close.

27. juuli 2026, 23:26 UTC

Illumina Inc shares are lower in after-market hours, continuing a decline over the past three sessions with no specific news identified.

24. juuli 2026, 17:46 UTC

Illumina Inc's shares are lower today, hitting a mid-morning low. Broader market sentiment may be affected by recent volatility in oil prices.

22. juuli 2026, 19:31 UTC

News

Illumina Inc shares are lower amid a report citing stagnant sales and concerns over management's investment opportunities. The company may need acquisitions for growth.

21. juuli 2026, 20:02 UTC

Correlated Moves
News

Illumina Inc's shares are higher, supported by broader market momentum and anticipation of upcoming earnings from major companies. The Russell 2000 Index also advanced.

20. juuli 2026, 19:56 UTC

Correlated Moves

Illumina Inc shares declined during Monday's session, paralleling a drop in the ARK Genomic Revolution ETF amid broader market weakness.

17. juuli 2026, 19:06 UTC

Illumina Inc shares are lower today amid broader market declines, particularly in technology and semiconductor stocks, following significant selling pressure in Asia.

16. juuli 2026, 22:06 UTC

Illumina Inc shares are lower in after-market hours, tracking broader market declines amid geopolitical tensions and mixed economic indicators.

15. juuli 2026, 18:51 UTC

Illumina Inc shares declined Wednesday, pulling back from earlier gains. No specific news was identified to explain this movement amid broader positive market trends.

14. juuli 2026, 19:36 UTC

News

Illumina shares rise as Canaccord raises price target to $190.00, despite a patent ruling against the company in Germany.

Võrdlus sarnastega

Hinnamuutus

Illumina Inc Prognoos

Hinnasiht

By TipRanks

-14.39% langus

12 kuu keskmine prognoos

Keskmine 194.93 USD  -14.39%

Kõrge 230 USD

Madal 113 USD

Põhineb 15 Wall Streeti analüütiku instrumendi Illumina Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

15 ratings

7

Osta

5

Hoia

3

Müü

Sentiment

By Acuity

24 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.
help-icon Live chat